ALOX5 and nonpapillary renal cell carcinoma: To confirm the functional importance of ALOX5 in ccRCC, it was next knocked down, with knockdown efficiency in 786-O and A498 cells being successfully confirmed through qPCR and Western immunoblotting (Figures 11A, B).